Research advances in indicators for early diagnosis of liver cirrhosis patients with renal impairment

Lu LiFang; Feng GuoHe

doi:10.3969/j.issn.1001-5256.2016.09.037

Issue 9

Sep. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(9): 1797-1800

PDF( 1517 KB)

Research advances in indicators for early diagnosis of liver cirrhosis patients with renal impairment

DOI: 10.3969/j.issn.1001-5256.2016.09.037

Department of Infectious Diseases,Shengjing Hospital of China Medical University

Received Date: 2016-04-15
Published Date: 2016-09-20

Abstract

Abstract

The liver is closely associated with the kidney,and liver injury in various stages can cause various kidney diseases to varying degrees,which further lead to renal impairment. Such renal impairment in the early stage is often functional and can be reversed by drugs,otherwise it can progress to hepatorenal syndrome,cause acute renal failure,and even threaten human life. The indicators such as serum creatinine and urea nitrogen have a limited effect in the early diagnosis of renal impairment and cannot be used for early monitoring and diagnosis of liver cirrhosis patients with renal impairment. Therefore,early monitoring of liver cirrhosis patients with renal impairment has always been a hot topic in this field. This article summarizes the research advances in the indicators for early diagnosis of renal impairment.
- liver cirrhosis,
- kidney diseases,
- diagnosis,
- review

FullText(HTML)

References(35)

References

[1]CHEN YC,SU YC,LI CY,et al.13-year nationwide cohort study of chronic kidney disease risk among treatment-na6ve patients with chronic hepatitis B in Taiwan[J].BMC Nephrol,2015,16:110.

[2]ZUO L,SUN FX,WANG XB,et al.Clinical analysis of 298 cases of liver cirrhosis and renal dysfunction[J].Chin J Hepatol,2014,22(7):504-508.(in Chinese)左璐,孙凤霞,王宪波,等.298例乙型肝炎肝硬化患者合并肾功能不全情况分析[J].中华肝脏病杂志,2014,22(7):504-508.

[3]ASKENAZI D.Are we ready for the clinical use of novel acute kidney injury biomarkers?[J].Pediatr Nephrol,2012,27(9):1423-1425.

[4]URRUNAGA NH,MINDIKOGLU AL,ROCKEY DC.Renal dysfunction in cirrhosis[J].Curr Opin Gastroenterol,2015,31(3):215-223.

[5]HSIAO PG,HSIEH CA,YEH CF,et al.Early prediction of acute kidney injury in patients with acute myocardial injury[J].J Crit Care,2012,27(5):525.e1-e7.

[6]RUIZ-DEL-RBO L,ACHECAR L,SERRADILLA R,et al.Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis,portal hypertension,and a normal creatinine[J].Hepatology,2013,58(5):1732-1741.

[7]TSIEN CD,RABIE R,WONG F.Acute kidney injury in decompensated cirrhosis[J].Gut,2013,62(1):131-137.

[8]KOSTRUBIEC M,LABYK A,PEDOWSKA-WIOSZEK J,et al.Neutrophil gelatinase-associated lipocalin,cystatin C and e GFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism[J].Heart,2012,98(16):1221-1228.

[9]MURTY MS.Serum cystatin C as a marker of renal function in detection of early acute kidney injury[J].Indian J Nephrol,2013,23(3):180-183.

[10]HAHN WH,BAE CW.Reference intervals of serum cystatin C/creatinine ratio of 30 postnatal days in neonates[J].Pediatr Nephrol,2013,28(9):1420-1423.

[11]ASSAL HS,TAWFEEK S,RASHEED EA,et al.Serum cystatinc and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus[J].Clinical Med Insights,2013,6(5):7-13.

[12]STEVENS LA,SCHMID CH,GREENE T,et al.Factors other than glomerular filtration rate affect serum cystatin C levels[J].Kidney Int,2009,75(6):652-660.

[13]INKER LA,SCHMID CH,TIGHIOUART H,et al.Estimating glomerular filtration rate from serum creatinine and cystatin C[J].N Engl,J Med,2012,367(1):20-29.

[14]JONAS B,ANDERS G,ANDERS L,et al.Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays:a cross-sectional study in sweden[J].Clin Chem Lab Med,2015,53(3):403-414.

[15]ZHU Y,YE XH,ZHU B,et al.Comparisons between the 2012new CKDEPI(chronic kidney disease epidemiologycollaboration)equations and other four approved equations[J].PLo S One,2014,9(1):e84688.

[16]MINDIKOGLU AL,DOWLING TC,WEIR MR,et al.Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis[J].Hepatology,2014,59(4):1532-1542.

[17]KRONES E,FICKERT P,ZITTA S,et al.The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis[J].BMC Nephrology,2015,16(1):196.

[18]PARAGAS N,QIU A,HOLLMEN M,et al.NGAL-Siderocalin in kidney disease[J].Biochim Biophys Acta,2012,1823(9):1451-1458.

[19]HAASE-FIELITZ A,HAASE M,DEVARAJAN P,et al.Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury:a critical evaluation of current status[J].Ann Clin Biochem,2014,51(Pt 3):335-351.

[20]HEISE D,RENTSCH K,BRAEUER A,et al.Comparison of urinary neutrophil glucosaminidase-associated lipocalin,systatin C,andα1-microglobulin for early detection of acute renal injury after cardiac surgery[J].Eur J Cardiothorac Surg,2011,39(1):38-43.

[21]MARTENSSON J,BELLOMO R.The rise and fall of NGAL acute kidney injury[J].Blood Purif,2014,37(4):304-310.

[22]NICKOLAS TL,FORSTER CS,SISE ME,et al.NGAL(Lcn2)monomer is associated with tubulointerstitial damage in chronic kidney disease[J].Kidney Int,2012,82(6):718-722.

[23]WONG F,O'LEARY JG,REDDY KP,et al.New consensus definition of acute kidney injury accurately predicts 30-day mortality in patient with cirrhosis and infection[J].Gastroenterology,2013,145(6):1280-1288.

[24]WAN ZH,WANG JJ,XIE GM,et al.Significance of serum cystatin C level for early diagnosis of acute kidney injury in patients with acute-on-chronic liver ailure[J].J Clin Hepatol,2014,30(7):666-669.

[25]LIU KD,YANG W,ANDERSON AH,et al.Urineneutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease[J].Kidney Int,2013,83(5):909-914.

[26]DONADIO C.Effect of glomerular filtration rate impairment on diagnostic performance of neut rophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients[J].Crit Care,2014,18(1):r39.

[27]SONG LL,ZHAO J,YU JY,et al.Up-regulation effect of cyclosporine A on level of kidney injury molealle-Ⅰin culture supernatant of human kidney cells and its mechanism[J].J Jilin Univ:Med Edit,2014,40(6):1201-1205.(in Chinese)宋莲莲,赵军,于金宇,等.环孢素引起肾小管上皮细胞培养液中肾损伤分子-Ⅰ水平升高的机制[J].吉林大学学报:医学版,2014,40(6):1201-1205.

[28]OBERMLLER N,GEIGER H,WEIPERT C,et al.Current developments in early diagnosis of acute kidney injury[J].Int Urol Nephrol,2014,46(1):1-7.

[29]HOLZSCHEITER L,BECK C,RUTZ S,et al.NGAL,L-FABP,and KIM-1 in comparison to established markers of renal dysfunction[J].Clin Chem Lab Med,2014,52(4):537-546.

[30]HAZLE MA,GAJARSKI RJ,AIYAGARI R,et al.Urinary biomarkers and renal near-infrared spectroscopy predict intensive care unit outcomes after cardiac surgery in infants younger than 6monhs of age[J].J Thorac Cardiovasc Sury,2013,146(4):861-867.

[31]LUO JH,WU N.Value of serum kidney injury molecule-1 level in early predicting renal dysfunction seconary to liver cirrhosis[J].Lab Med Clin,2015,12(2):188-190.

[32]VIVIER PH,STOREY P,RUSINEK H,et al.Kidney function:glomerular filtration rate measurement with MR renography in patients with cirrhosis[J].Radiology,2011,259(2):462-470.

[33]GUO SB,DUAN ZJ,LI Q,et al.Effect of heme oxygenase-1 on renalfunction in rats with liver cirrhosis[J].World J Gastroenterol,2011,17(3):322-328.

[34]ARAKI S,HANEDA M,KOYA D,et al.Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without ad vanced nephropath[J].Diabetes Care,2013,36(5):1248-1253.

[35]YONG K,OOI EM,DOGRA G,et al.Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial tiffness[J].Cytokine,2013,64(1):39-42.

Relative Articles

[1]	Li YANG, Ke SHI, Fangyuan GAO, Chongping RAN, Jie HOU, Xianbo WANG. Influencing factors for chronic kidney disease in patients with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(8): 1817-1821. doi: 10.3969/j.issn.1001-5256.2021.08.015
[2]	Luying ZHU, Yuchen LI, Lihua DENG, Jingtong WANG. Research advances in extrahepatic diseases associated with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(9): 2215-2219. doi: 10.3969/j.issn.1001-5256.2021.09.043
[3]	GONG Hang, HUANG Zhong, LIU XianLi. Application of artificial intelligence in various liver and pancreas diseases[J]. Journal of Clinical Hepatology, 2020, 36(12): 2865-2869. doi: 10.3969/j.issn.1001-5256.2020.12.048
[4]	Luo WenPing, Ma Hong, Wang Yu. Advances in the application of transient elastography in noninvasive diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2019, 35(3): 635-639. doi: 10.3969/j.issn.1001-5256.2019.03.041
[5]	Zheng ShaoQiu, Wang QiZhi. Current status and prospects of research on noninvasive diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2019, 35(1): 197-200. doi: 10.3969/j.issn.1001-5256.2019.01.043
[6]	Li JiaNa, Zheng RuiQi, Li Na, Hu YuLin. The biological characteristics of GP73 and its value in the diagnosis of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1361-1364. doi: 10.3969/j.issn.1001-5256.2019.06.040
[7]	Liu QinYu, Li Hai. Changes in diagnostic criteria for hepatorenal syndrome and the application of new renal injury indices in cirrhotic patients[J]. Journal of Clinical Hepatology, 2018, 34(6): 1308-1312. doi: 10.3969/j.issn.1001-5256.2018.06.038
[8]	Hu Ying, Li LiangPing. Serological noninvasive diagnosis of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2018, 34(9): 2004-2007. doi: 10.3969/j.issn.1001-5256.2018.09.037
[9]	Su LiHong, Zhu XinYu, Zhang LiaoYun. Diagnosis strategies for intrahepatic cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2017, 33(1): 180-183. doi: 10.3969/j.issn.1001-5256.2017.01.042
[10]	Fang Dan, Chen ZheYu. Diagnosis and treatment of hepatic alveolar echinococcosis[J]. Journal of Clinical Hepatology, 2017, 33(5): 990-993. doi: 10.3969/j.issn.1001-5256.2017.05.042
[11]	Yang ErNa, Cao WuKui. Research advances in noninvasive diagnosis of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2209-2213. doi: 10.3969/j.issn.1001-5256.2017.11.035
[12]	Li BoLong, Peng XinYu, Qiao Fei, Xu Qiang, Zhao BoWen. Application of spectral computed tomography in diagnosis of liver and gallbladder diseases[J]. Journal of Clinical Hepatology, 2017, 33(3): 593-598. doi: 10.3969/j.issn.1001-5256.2017.03.043
[13]	Zhang XiaoTong, Guo LiPing. Value of ultrasonic elastography in diagnosis of liver diseases[J]. Journal of Clinical Hepatology, 2016, 32(11): 2210-2213. doi: 10.3969/j.issn.1001-5256.2016.11.048
[14]	Yang MingLei, Yao DingKang. Application of magnetic resonance elastography as a non-invasive technique for diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2016, 32(3): 588-592. doi: 10.3969/j.issn.1001-5256.2016.03.042
[15]	Li Mi, Nie QingHe. The progress of Fibro Scan technique for diagnosis of hepatocellular carcinoma value[J]. Journal of Clinical Hepatology, 2015, 31(6): 969-973. doi: 10.3969/j.issn.1001-5256.2015.06.035
[16]	Wu Qiong, Xu GuangHua. Recent research findings on non-invasive diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 295-299. doi: 10.3969/j.issn.1001-5256.2015.02.040
[17]	Zhao Wei. Clinical significance of plasma and urine neutrophil gelatinase-associated lipocalin levels in diagnosis of acute kindney injury in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1874-1877. doi: 10.3969/j.issn.1001-5256.2015.11.025
[18]	Zhao Ning, Li ZhiWei. Diagnosis and treatment of acute hepatitis C[J]. Journal of Clinical Hepatology, 2014, 30(6): 489-492. doi: 10.3969/j.issn.1001-5256.2014.06.003
[19]	Peng XiaoFang, Liu HaiYing. Research advances in circulating miRNAs for diagnosis of hepatobiliary diseases[J]. Journal of Clinical Hepatology, 2014, 30(9): 965-968. doi: 10.3969/j.issn.1001-5256.2014.09.032
[20]	Cai JunJun, Han Tao. Diagnosis and treatment of acute kidney injury in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(12): 1352-1356. doi: 10.3969/j.issn.1001-5256.2014.12.030

Supplements(0)

Cited By

Cited by

Periodical cited type(5)

1.	陈乃刚，王彦润，俱京涛，张士朋，王晓纯. CT增强扫描对肾功能损伤诊断价值的研究. 临床放射学杂志. 2021(07): 1422-1425 .
2.	张洁冰，郭宏华. 乙型肝炎肝硬化合并肾损伤及抗病毒药物的应用. 临床肝胆病杂志. 2019(01): 191-196 . 本站查看
3.	周一萌，王岩，路丽芳，冯国和. 肝硬化患者并发肾损害危险因素的回顾性分析. 中国现代医学杂志. 2019(20): 74-78 .
4.	张玉玲，褚志强，李婧瑶，季倩. CT增强扫描评估肝硬化患者早期肾功能损伤的初步研究. 放射学实践. 2019(12): 1364-1369 .
5.	姜建平. 终末期肝病并发肝肾综合征患者预后的临床影响因素分析. 中国当代医药. 2017(26): 23-25 .

Other cited types(2)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2222) PDF downloads(490)

Research advances in indicators for early diagnosis of liver cirrhosis patients with renal impairment

DOI: 10.3969/j.issn.1001-5256.2016.09.037